Riverview Trust Company’s GSK GSK Stock Holding History

Riverview Trust Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-654	Closed	-$31K	–	229
2020 Q3	$31K	Hold	654	–	–	0.04%	175
2020 Q2	$33K	Hold	654	–	–	0.03%	174
2020 Q1	$31K	Hold	654	–	–	0.03%	170
2019 Q4	$38K	Hold	654	–	–	0.03%	183
2019 Q3	$35K	Hold	654	–	–	0.02%	188
2019 Q2	$33K	Sell	654 -94	-13%	-$4.72K	0.02%	187
2019 Q1	$39K	Buy	+748	New	+$37.4K	0.03%	172

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Riverview Trust Company's GSK Position: Q4 2020 in Review

Riverview Trust Company sold out of GSK (GSK) in Q4 2020, closing a stake of 654 shares — an estimated $31K sold.

Riverview Trust Company first reported a position in GSK in Q1 2019 and held it in 7 quarters. The position peaked at $39K in Q1 2019. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

Riverview Trust Company reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
Riverview Trust Company sold 654 GSK shares in Q4 2020, an estimated $31K.
Riverview Trust Company first reported a position in GSK in Q1 2019 and held it in 7 quarters.
Riverview Trust Company's GSK position peaked at $39K in Q1 2019.
818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Riverview Trust Company's 13F filing for Q4 2020, filed 22 Jan 2021.